Literature DB >> 34319475

Improvement in Breast Reconstruction Disparities following Medicaid Expansion under the Affordable Care Act.

Kirithiga Ramalingam1, Liang Ji1, Saeed Pairawan1, David Caba Molina1, Sharon S Lum2.   

Abstract

BACKGROUND: Under the Affordable Care Act, Medicaid expansion effective 1 January 2014 aimed to increase access to health care. We sought to determine the association of Medicaid expansion with disparities in utilization of breast reconstruction.
METHODS: Non-Hispanic Black (NHB) and White (NHW) breast cancer patients undergoing mastectomy +/- reconstruction between 2010 and 2017 were selected from the National Cancer Database. Annual trends for utilization of breast reconstruction by race, income, and education were evaluated by Medicaid expansion status using difference-in-differences regression analyses. Medicaid expansion was categorized by expansion date as early (2010-2013), 2014 (1/2014), late (after 1/2014), or no expansion.
RESULTS: Of 443,607 patients, 36.3% (n = 161,128) underwent reconstruction, 13.1% (n = 58,249) were NHB, 16.8% (n = 74,430) had median income < $40,227, and 17.1% (n = 75,718) were in the lowest education quartile. In non-expansion states, lower proportions of NHB patients underwent reconstruction than NHW patients in all years, with the smallest disparity (NHB% - NHW%) (- 6.4%) in 2017. Decreases in disparities between NHB and NHW patients were seen with the smallest difference observed in 2014 (- 2.5%) in early-expansion states, in 2017 (- 0.7%) in 1/2014 expansion states, and in 2017 (- 4.5%) in late-expansion states. Similar findings for convergence of reconstruction utilization rates for the lowest two education levels and lowest two income quartiles were found with Medicaid expansion, with no convergence seen in non-expansion states over the study period.
CONCLUSIONS: Some improvement in breast reconstruction disparities followed Medicaid expansion. Failure to improve parity without Medicaid expansion should be a consideration with any modifications to Medicaid access.
© 2021. Society of Surgical Oncology.

Entities:  

Year:  2021        PMID: 34319475     DOI: 10.1245/s10434-021-10495-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  18 in total

1.  A prospective and randomized study, "SVEA," comparing effects of three methods for delayed breast reconstruction on quality of life, patient-defined problem areas of life, and cosmetic result.

Authors:  Y Brandberg; M Malm; L Blomqvist
Journal:  Plast Reconstr Surg       Date:  2000-01       Impact factor: 4.730

2.  Are mastectomy rates really increasing in the United States?

Authors:  Elizabeth B Habermann; Andrea Abbott; Helen M Parsons; Beth A Virnig; Waddah B Al-Refaie; Todd M Tuttle
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

3.  A paradigm shift in U.S. Breast reconstruction: increasing implant rates.

Authors:  Claudia R Albornoz; Peter B Bach; Babak J Mehrara; Joseph J Disa; Andrea L Pusic; Colleen M McCarthy; Peter G Cordeiro; Evan Matros
Journal:  Plast Reconstr Surg       Date:  2013-01       Impact factor: 4.730

4.  Racial disparities in postmastectomy breast reconstruction: National trends in utilization from 2005 to 2014.

Authors:  Sherise Epstein; Bao N Tran; Justin B Cohen; Samuel J Lin; Dhruv Singhal; Bernard T Lee
Journal:  Cancer       Date:  2018-04-16       Impact factor: 6.860

5.  Differences in the Reporting of Racial and Socioeconomic Disparities among Three Large National Databases for Breast Reconstruction.

Authors:  Parisa Kamali; Sara L Zettervall; Winona Wu; Ahmed M S Ibrahim; Caroline Medin; Hinne A Rakhorst; Marc L Schermerhorn; Bernard T Lee; Samuel J Lin
Journal:  Plast Reconstr Surg       Date:  2017-04       Impact factor: 4.730

6.  Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study.

Authors:  Patricia A Ganz; Katherine A Desmond; Beth Leedham; Julia H Rowland; Beth E Meyerowitz; Thomas R Belin
Journal:  J Natl Cancer Inst       Date:  2002-01-02       Impact factor: 13.506

7.  Race and Breast Cancer Reconstruction: Is There a Health Care Disparity?

Authors:  Ketan Sharma; David Grant; Rajiv Parikh; Terence Myckatyn
Journal:  Plast Reconstr Surg       Date:  2016-08       Impact factor: 4.730

8.  Immediate postmastectomy reconstruction is associated with improved breast cancer-specific survival: evidence and new challenges from the Surveillance, Epidemiology, and End Results database.

Authors:  Michael Bezuhly; Claire Temple; Leif J Sigurdson; Roger B Davis; Gordon Flowerdew; E Francis Cook
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

9.  Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base.

Authors:  Mark Sisco; Hongyan Du; Jeremy P Warner; Michael A Howard; David P Winchester; Katharine Yao
Journal:  J Am Coll Surg       Date:  2012-08-24       Impact factor: 6.113

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more
  3 in total

1.  Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer.

Authors:  Adrienne N Cobb; Taiwo Adesoye; Mediget Teshome
Journal:  Ann Surg Oncol       Date:  2022-02-12       Impact factor: 4.339

2.  ASO Author Reflections: Medicaid Expansion is Key in Mitigating Surgical Disparities in Low-Income Breast Cancer Patients.

Authors:  Samilia Obeng-Gyasi; Johnie Rose; Siran Koroukian
Journal:  Ann Surg Oncol       Date:  2021-11-27       Impact factor: 5.344

3.  22nd Annual Virtual Meeting of the American Society of Breast Surgeons: Science, Innovation, and Practice Changes.

Authors:  Katherina Zabicki Calvillo; Sarah L Blair; Henry M Kuerer
Journal:  Ann Surg Oncol       Date:  2021-08-07       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.